Oct 28, 2009 2:59pm EDT SCYNEXIS to Present HCV Data on Novel Cyclophilin Inhibitor SCY-635 at AASLD Annual Meeting
Oct 27, 2009 8:00am EDT SCYNEXIS Receives Milestone Payment in Oncology Collaboration with Merck & Co., Inc.
Jan 08, 2009 9:00am EST First Candidate from SCYNEXIS' Novel Cyclophilin Inhibitor Platform, SCY-635, Establishes Proof of Concept in HCV-Infected Adults
Dec 11, 2008 9:00am EST SCYNEXIS and DNDi Extend Collaboration to Identify Drug Candidates to Treat Sleeping Sickness
Nov 03, 2008 8:03am EST SCYNEXIS to Present Preclinical HCV Data on Novel Cyclophillin Inhibitor SCY-635 at AASLD Annual Meeting
Jun 24, 2008 3:00pm EDT Media Advisory - Public Briefing: Uniting the Global Research Community Against Neglected Diseases
Jun 09, 2008 8:03am EDT SCYNEXIS Convenes Renowned Scientists for Symposium on the Therapeutic Promise of Cyclophilin Inhibitors
Jan 07, 2008 10:00am EST SCYNEXIS to Present at the JPMorgan Healthcare Conference on January 8, 2008
